These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1846943)

  • 21. Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in rat substantia nigra.
    Zhang J; Chiodo LA; Freeman AS
    J Pharmacol Exp Ther; 1994 Apr; 269(1):313-21. PubMed ID: 7513359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
    Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
    J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MPP+ induced substantia nigra degeneration is attenuated in nNOS knockout mice.
    Matthews RT; Beal MF; Fallon J; Fedorchak K; Huang PL; Fishman MC; Hyman BT
    Neurobiol Dis; 1997; 4(2):114-21. PubMed ID: 9331901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 1-methyl-4-phenylpyridinium on radioligand binding to the NMDA receptor complex.
    Sundström E; Mo LL
    Res Commun Mol Pathol Pharmacol; 1995 May; 88(2):131-6. PubMed ID: 7670845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NMDA antagonists partially protect against MPTP induced neurotoxicity in mice.
    Brouillet E; Beal MF
    Neuroreport; 1993 Apr; 4(4):387-90. PubMed ID: 8499594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo protection of striatum from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists.
    Santiago M; Venero JL; Machado A; Cano J
    Brain Res; 1992 Jul; 586(2):203-7. PubMed ID: 1521154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-neurotoxicity trends of analogues of 1-methyl-4-phenylpyridinium (MPP+), the cytotoxic metabolite of the dopaminergic neurotoxin MPTP.
    Arora PK; Riachi NJ; Fiedler GC; Singh MP; Abdallah F; Harik SI; Sayre LM
    Life Sci; 1990; 46(5):379-90. PubMed ID: 2304377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates.
    Lange KW; Löschmann PA; Sofic E; Burg M; Horowski R; Kalveram KT; Wachtel H; Riederer P
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):586-92. PubMed ID: 7907775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice.
    Kupsch A; Löschmann PA; Sauer H; Arnold G; Renner P; Pufal D; Burg M; Wachtel H; ten Bruggencate G; Oertel WH
    Brain Res; 1992 Oct; 592(1-2):74-83. PubMed ID: 1360317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures.
    Michel PP; Agid Y
    Brain Res; 1992 Dec; 597(2):233-40. PubMed ID: 1361874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
    Wu RM; Mohanakumar KP; Murphy DL; Chiueh CC
    Ann N Y Acad Sci; 1994 Nov; 738():214-21. PubMed ID: 7832430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The N-methyl-D-aspartate antagonist MK-801 fails to protect dopaminergic neurons from 1-methyl-4-phenylpyridinium toxicity in vitro.
    Finiels-Marlier F; Marini AM; Williams P; Paul SM
    J Neurochem; 1993 May; 60(5):1968-71. PubMed ID: 8473912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Striatal dopaminergic toxicity following intranigral injection in rats of 2-methyl-norharman, a beta-carbolinium analog of N-methyl-4-phenylpyridinium ion (MPP+).
    Neafsey EJ; Drucker G; Raikoff K; Collins MA
    Neurosci Lett; 1989 Nov; 105(3):344-9. PubMed ID: 2594220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra.
    Langston JW; Irwin I; Langston EB; Forno LS
    Neurosci Lett; 1984 Jul; 48(1):87-92. PubMed ID: 6332288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of antioxidants on L-glutamate and N-methyl-4-phenylpyridinium ion induced-neurotoxicity in PC12 cells.
    Mazzio E; Huber J; Darling S; Harris N; Soliman KF
    Neurotoxicology; 2001 Apr; 22(2):283-8. PubMed ID: 11405259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis.
    Marini AM; Paul SM
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6555-9. PubMed ID: 1385875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.
    Frim DM; Uhler TA; Galpern WR; Beal MF; Breakefield XO; Isacson O
    Proc Natl Acad Sci U S A; 1994 May; 91(11):5104-8. PubMed ID: 8197193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.
    Sonsalla PK; Nicklas WJ; Heikkila RE
    Science; 1989 Jan; 243(4889):398-400. PubMed ID: 2563176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.